A real life retrospective analysis of drug expenditure reveals no significant cost difference between infliximab and adalimumab in the treatment of Adult Crohn's Disease
- Lookup NU author(s)
- Dr Christopher Lamb
- Maria Price
- Dr John Mansfield
|
|
|
|
| Author(s) | | Lamb CA, Price M, Robinson M, Gunn MC, Thompson NP, Mansfield JC |
| Editor(s) | | |
| Publication type | | Conference Proceedings (inc. Abstract) |
| Conference Name | | Annual Meeting of the British Society of Gastroenterology |
| Conference Location | | Birmingham, England |
| Year of Conference | | 2011 |
| Date | | 14-17 March 2011 |
| Volume | | 60 (Suppl. 1) |
| Pages | | A251-A252 |
| |
|
| ISBN | | |
| |  |
|
|
|
| Full text for this publication is not currently held within this repository. Alternative links are provided below where available. |
|
|
|
| Publisher | | Gut: BMJ Publishing Group |
| URL | | http://dx.doi.org/10.1136/gut.2011.239301.534 |
| DOI | | 10.1136/gut.2011.239301.534 |
|
|
Actions | |   |
| Library holdings | | Search Newcastle University Library for this item |
